Citadel Advisors’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Citadel Advisors’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-178,900	Closed	-$25.1M	–	11873
2020 Q3	$25.1M	Sell	178,900 -49,800	-22%	-$6.07M	0.01%	1382
2020 Q2	$17.2M	Buy	228,700 +144,000	+170%	+$7.54M	0.01%	1650
2020 Q1	$2.42M	Buy	84,700 +42,200	+99%	+$1.09M	﹤0.01%	3843
2019 Q4	$1.06M	Buy	42,500 +12,500	+42%	+$299K	﹤0.01%	5467
2019 Q3	$523K	Buy	+30,000	New	+$907K	﹤0.01%	6666

Citadel Advisors's LVGO Position: Q4 2020 in Review

Citadel Advisors sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 206,785 shares — an estimated $29M sold.

Citadel Advisors first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $29M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Citadel Advisors reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 206,785 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $29M.
Citadel Advisors first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Citadel Advisors's Livongo Health, Inc. Common Stock position peaked at $29M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.